2013年10月22-24日中国·北京|新疆大厦药品安全是当前新闻的常见议题,也是大众所关注的热点之一。优质的安全数据是药品审批的必要条件。相继出台的策法规均强调了药物安全和上市后药品监测的重要性。为此,了解如何进行药物安全监测和报告所需的途径、运作体系监管过程,对产品安全性的风险评估、预防药品可能给消费者带来的安全风险以及避免产品召回都具有十分重要的意义 October 22-24, 2013 Beijing, China | Xinjiang Building Drug safety is a common issue in current news. It is also one of the hot spots that people are concerned about. Quality safety data is a necessary condition for drug approval. The policies and regulations that have been promulgated successively emphasize the importance of drug safety and post-market drug monitoring. To this end it is important to understand how to conduct drug safety monitoring and reporting, operational system monitoring, risk assessment of product safety, prevention of potential safety risks to consumers and avoidance of product recalls